New research, guidelines and FDA decisions, each with a note on what it might change in a conversation with your surgeon, how certain it is, and links to the original sources.
How we choose news. Nothing here is sponsored. Mentioning a product isn't an endorsement, and an FDA clearance means a device was found substantially equivalent to existing ones, not proven better. Updated November 2026.
Registry
Revision hip patients still less likely to go straight home
According to coverage of the American Joint Replacement Registry's 2026 report, 66% of revision hip patients went home from the hospital in 2025, compared with 92% after a first elective hip replacement. Infection made up 26.6% of hip revisions.
What this could change in a conversation with your surgeon: Plan ahead for help at home or a short rehab stay.